Acupuncture for Prevention of Recurrent Urinary Tract Infections. (SARUTI)
Primary Purpose
Recurrent Urinary Tract Infection
Status
Completed
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
acupuncture
Cranberry products
Sponsored by
About this trial
This is an interventional prevention trial for Recurrent Urinary Tract Infection
Eligibility Criteria
Inclusion Criteria:
- Recurrent UTIs: Two or more symptomatic UTIs within the last six 6 months or 3 or more infections within the last 12 months.
- At least two positive urine culture within this period of time
- No evidence of current UTI at the time of inclusion
- Women, Age 18 - 90 years
- Informed consent
Exclusion Criteria:
- Pregnancy
- Urogenital anatomical abnormality
- Evidence of kidney stones
- Indwelling catheter
- systemic diseases such as renal insufficiency, transplantation, diabetes, or immunodeficiency
Sites / Locations
- Department of Gynecology/ Medical University of Graz
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Other
Arm Label
acupuncture
Control
Arm Description
12 acupuncture treatments according to a standardized protocol, plus recommendation for use of cranberry products
Recommendation for use of cranberry products only
Outcomes
Primary Outcome Measures
Urinary tract infection (UTI)
Number of women with no acute UTI at 6 months
Secondary Outcome Measures
Urinary symptoms
Occurrence of urinary symptoms without signs of UTI
Study diary
Use of cranberry products (type, length and amount) assessed by the study diary
Health related quality of life
Health related quality of life as measured by the Kings Health Questionnaire
Full Information
NCT ID
NCT02705495
First Posted
February 1, 2016
Last Updated
August 4, 2022
Sponsor
Medical University of Graz
1. Study Identification
Unique Protocol Identification Number
NCT02705495
Brief Title
Acupuncture for Prevention of Recurrent Urinary Tract Infections.
Acronym
SARUTI
Official Title
Segmental and Ear Acupuncture for Prevention of Recurrent Urinary Tract Infections(SARUTI Study): a Multicenter Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
May 2015 (undefined)
Primary Completion Date
December 2021 (Actual)
Study Completion Date
June 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medical University of Graz
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
In this multi-centre prospective randomized controlled trial the efficacy of segmental acupuncture in the prevention of recurrent urinary tract infections will be assessed. The study (acupuncture) group will receive 12 acupuncture treatments according to a standardized protocol, plus recommendation for use of cranberry products. The control group will receive recommendation for use of cranberry products only.
Detailed Description
Background 1.1. Urinary tract infection
Urinary tract infections (UTI) are considered to be the most common bacterial infections, with approximately 80% of all UTIs occurring in women (1). Nearly one in three women is expected to have at least one episode of UTI by the age of 24 years and almost half of all women will experience one UTI during their lifetime (2). Recurrence affect approximately 20-30% of women with initial UTI, although recurrence rates vary widely (3).
Recurrent UTIs are a common problem seen in clinical practice with important medical, social and financial implications. Prophylaxis of recurrent UTI is an ongoing challenge with several different management strategies being used (4). Low dose antibiotic prophylaxis for several months is effective, but fosters the development of antibiotic resistance of the causative microorganisms, but also the commensal flora.(4-8). In postmenopausal women vaginal estrogen therapy reduces symptomatic UTI episodes (1, 7). Further prevention strategies include the oral immunostimulant OM-89, the vaginal vaccine Urovac, lactobacilli prophylaxis, cranberry products and acupuncture (5, 7, 9).
1.2.Cranberry products Cranberries have been used in the prevention of UTIs for many years. Cranberries contain two compounds with antiadherence properties that prevent fimbriated Escherichia coli from adhering to uroepithelial cells in the urinary tract (10). A recent review of 24 studies showed that the use of various cranberry products may have a small benefit for women with recurrent UTIs, although differences were not statistically significant (11).
1.3. Acupuncture treatment The effectiveness of acupuncture has been established for a series of different conditions (12, 13). Up to date there are only two clinical trials studying the effect of acupuncture on the prevention of recurrent UTI, both conducted from the same research group. In one controlled trial of 67 adult women acupuncture was significantly more effective in preventing recurrent UTI compared to sham acupuncture than no treatment over an observation period of 6 months (14). In the second trial of 100 women acupuncture, administered twice weekly for 4 weeks, was significantly more effective in reducing the number of UTIs, but also in reducing the volume of residual urine. Acupuncture points were chosen according to patients´ individual diagnoses following traditional Chinese medical patterns. (15)
Study aims The present study aims to compare acupuncture treatment with standard treatment (recommendation for cranberry intake) in the treatment of uncomplicated recurrent UTIs in women and is designed as a prospective randomized controlled trial. We will assess the number of acute lower UTIs and subsequent treatment, the type and amount of self medication (cranberry products and others), health related quality of life and treatment satisfaction within a defined period of time.
The results from this study will help to guide clinical practice with level I evidence and allow for effective treatment with regard to patient needs.
Methods/ Workplan This patient oriented non-profit clinical study is designed as a randomised controlled trial (6 months) with a follow-up period of 12 months.
Active recruitment: 12 months Randomised controlled trial: 6 months Short-term Follow-up: 12 months 3.1. Active recruitment After Ethics Committee approval patient recruitment will be started. Information material about the study, including contact details, will be provided at the outpatient clinics of the Dep. of Gynecology, the Dep. of Urology, and other local health care providers. During an initial visit patients will be informed about the study and inclusion and exclusion criteria will be evaluated. A structured medical history, including assessment of previous UTIs and other urogenital tract symptoms, will be obtained. After written informed consent is obtained participants will be randomized.
3.2. Randomized Controlled Trial (6 months)
At the time of randomization patients must not have signs or symptoms of an acute UTI, and must not currently receive antibiotic treatment. Randomizing will be done electronically (www.randomizer.at). Patients will be randomized in one of two treatment groups without stratification with a planned ratio of 1:1:
Acupuncture treatment group 12 acupuncture treatments according to a standardized protocol plus recommendation for use of cranberry products
Standard treatment group Recommendation for use of cranberry products only
Participants will be contacted bimonthly by telephone and asked about occurrence of UTIs, adverse events, study adherence and completion of study diary. At 6 months a control visit will be scheduled, the RCT will be completed and the main outcome parameter (number of women with no acute UTIs) and secondary outcome parameters (9.2.) will be assessed.
This will be followed by a 12 months short-term Follow-up. 3.3. Short-term Follow-up (12 months) Patients of both treatment groups may use any prophylactic treatment. Participants will be contacted bimonthly by telephone and asked about occurrence of UTIs, adverse events, and use of prophylactic and therapeutic treatments for UTIs.
The study is designed according to the 2010 CONSORT guidelines(16) and the STRICTA (Standards for Reporting Interventions in Clinical Trials of Acupuncture) guidelines (17).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Recurrent Urinary Tract Infection
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
136 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
acupuncture
Arm Type
Active Comparator
Arm Description
12 acupuncture treatments according to a standardized protocol, plus recommendation for use of cranberry products
Arm Title
Control
Arm Type
Other
Arm Description
Recommendation for use of cranberry products only
Intervention Type
Other
Intervention Name(s)
acupuncture
Intervention Description
Acupuncture will be performed according to the physiological concept of segmental acupuncture. A fixed schema of acupuncture points will be used irrespective of TCM diagnosis. Needles will be inserted approximately 10 mm under the skin. The "deqi sensation" (a sensation described as numbness, heaviness, and distension) may be obtained, but will not be specifically aimed for. The acupuncture protocol includes body and ear acupuncture.
Intervention Type
Drug
Intervention Name(s)
Cranberry products
Other Intervention Name(s)
Cranberry tablets and juice
Intervention Description
Participants will receive Cranberry products (Urgenin Blasenkapseln® and/or Alpinamed Preiselbeer Granulat ®) - use is recommended but not obligatory.
Primary Outcome Measure Information:
Title
Urinary tract infection (UTI)
Description
Number of women with no acute UTI at 6 months
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Urinary symptoms
Description
Occurrence of urinary symptoms without signs of UTI
Time Frame
6 months
Title
Study diary
Description
Use of cranberry products (type, length and amount) assessed by the study diary
Time Frame
6 months
Title
Health related quality of life
Description
Health related quality of life as measured by the Kings Health Questionnaire
Time Frame
6 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Recurrent UTIs: Two or more symptomatic UTIs within the last six 6 months or 3 or more infections within the last 12 months.
At least two positive urine culture within this period of time
No evidence of current UTI at the time of inclusion
Women, Age 18 - 90 years
Informed consent
Exclusion Criteria:
Pregnancy
Urogenital anatomical abnormality
Evidence of kidney stones
Indwelling catheter
systemic diseases such as renal insufficiency, transplantation, diabetes, or immunodeficiency
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gerda Trutnovsky
Organizational Affiliation
Medical University of Graz
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Gynecology/ Medical University of Graz
City
Graz
ZIP/Postal Code
8036
Country
Austria
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Acupuncture for Prevention of Recurrent Urinary Tract Infections.
We'll reach out to this number within 24 hrs